India’s Public Hospitals Teeter on the Brink as Private Equity Bets Billions on Healthcare Boom
Fiscal strain from soaring oil prices and chronic underfunding push state-run hospitals to breaking point, while investors flock to a privatized healthcare goldmine—deepening inequality in a system already split between haves and have-nots.
India’s healthcare system is fracturing along stark financial fault lines. As global oil market volatility tightens the government’s budgetary noose, public hospitals—long the backbone of care for the country’s poorest—are buckling under the weight of neglect. Meanwhile, private equity firms are pouring unprecedented capital into India’s private hospital sector, drawn by the promise of high returns in a market where demand for quality care far outstrips supply. The divergence is not just economic; it is a crisis of equity, access, and the very notion of healthcare as a public good.
The consequences are already visible. In Delhi’s overcrowded Safdarjung Hospital, patients sleep on floors as wards overflow with cases that could have been prevented with timely primary care. In rural Bihar, district hospitals lack basic diagnostic equipment, forcing families to travel hundreds of kilometers for treatment. At the same time, in Mumbai’s glitzy private hospitals, investors-backed chains like Max Healthcare and Medicover are expanding aggressively, offering cutting-edge care—at a price most Indians cannot afford.
The government’s response has been a mix of denial and delay. Despite repeated warnings from health economists and international agencies, public healthcare spending remains stubbornly low, hovering around 1.2% to 1.5% of GDP—far below the global average of 6%. The fiscal strain is exacerbated by India’s dependence on imported oil, which forces the government to divert funds from social sectors to stabilize fuel prices. The result is a system where the poor are left to fend for themselves, while the wealthy—and the investors betting on their care—prosper.
—
What Happened
The past year has laid bare the contradictions in India’s healthcare system. In June 2024, Maxivision Eye Care, a chain of specialty eye hospitals backed by Southeast Asian private equity firm Quadria Capital, announced plans to hire investment bankers for an initial public offering (IPO), according to sources cited by Reuters. The move is part of a broader strategy to expand Maxivision’s footprint across India, particularly in tier-2 and tier-3 cities where demand for eye care is growing but public facilities are scarce.
Around the same time, global investment giant KKR entered advanced negotiations to acquire a stake worth at least $1 billion in Medicover’s Indian hospital arm, another Reuters source revealed. If finalized, the deal would mark one of the largest private equity investments in India’s healthcare sector, eclipsing KKR’s 2021 acquisition of a majority stake in Max Healthcare for $600 million. Medicover, which operates hospitals in Europe and India, has been expanding rapidly in the country, focusing on high-margin specialties like oncology and cardiology.
These developments are not isolated. Private equity investments in Indian healthcare surged to $4.5 billion in 2023, up from $1.2 billion in 2020, according to data from Venture Intelligence. The influx of capital reflects a broader trend: investors are betting on India’s healthcare sector as a growth story, driven by a rising middle class, increasing chronic disease burdens, and a severe shortage of public healthcare infrastructure.
Yet, while private hospitals flourish, public hospitals are in freefall. The government’s fiscal deficit has widened due to a combination of rising fuel subsidies, lower-than-expected tax revenues, and the economic fallout from global oil price volatility. In 2022-23, India’s fuel subsidy bill nearly doubled to ₹2.2 trillion ($26.5 billion), up from ₹1.1 trillion ($13.2 billion) the previous year, according to the Petroleum Planning and Analysis Cell (PPAC). The spike forced the government to make painful cuts elsewhere, including a 15% reduction in planned allocations for the Ayushman Bharat health insurance scheme, as reported by The Hindu in March 2023.
The impact on public hospitals has been devastating. A 2023 report by the National Health Systems Resource Centre (NHSRC) found that nearly 40% of district hospitals in India lack basic diagnostic equipment, such as X-ray machines and ultrasound scanners. Staff shortages are equally severe: 60% of district hospitals operate with fewer than half the required number of doctors, nurses, and technicians. The report attributed these gaps to chronic underfunding, with state governments often failing to disburse allocated funds on time—or at all.
The crisis is not just about money; it is about lives. In Uttar Pradesh, India’s most populous state, public hospitals have reported a 30% increase in patient deaths due to delayed treatment, according to a 2023 investigation by IndiaSpend. In Maharashtra, doctors at government-run hospitals have gone on strike multiple times in the past year to protest unpaid salaries and unsafe working conditions. The strikes have disrupted care for thousands of patients, many of whom have no alternative but to wait—or worse, seek treatment from unqualified practitioners.
—
Why It Matters
The stakes could not be higher. India’s healthcare system is already one of the most unequal in the world. Nearly 60% of the population lacks health insurance, and out-of-pocket expenses account for over 60% of total healthcare spending—one of the highest rates globally, according to the World Health Organization (WHO). For millions of Indians, a single hospitalization can push a family into debt or force them to sell assets like land or livestock. The WHO estimates that healthcare costs drive 55 million Indians into poverty every year.
The growing divide between public and private healthcare is not just a matter of access; it is a matter of survival. Public hospitals, which serve as the primary—often only—option for the poor, are being starved of resources at a time when demand for their services is surging. India’s population is aging, and chronic diseases like diabetes, heart disease, and cancer are on the rise. The COVID-19 pandemic exposed the fragility of the public healthcare system, with hospitals overwhelmed by cases and oxygen shortages leading to preventable deaths.
Meanwhile, private equity’s growing footprint in healthcare raises serious questions about affordability and equity. Investor-backed hospitals often prioritize profitable specialties like cardiology, oncology, and orthopedics, while neglecting primary care, maternal health, and rural services. A 2022 study by the Public Health Foundation of India (PHFI) found that private hospitals in urban areas charge up to 10 times more than public hospitals for the same procedures. For example, a coronary artery bypass graft (CABG) surgery costs an average of ₹250,000 ($3,000) in a private hospital, compared to ₹50,000 ($600) in a public hospital. The study warned that unchecked private sector growth could exacerbate healthcare inequality, particularly in rural areas where 68% of India’s population resides.
The oil market’s impact on healthcare adds another layer of complexity. India imports over 80% of its crude oil, making it highly vulnerable to global price shocks. When oil prices spike—as they did after Russia’s invasion of Ukraine in 2022—the government faces a difficult choice: either pass the cost on to consumers, risking inflation and political backlash, or absorb the cost through subsidies, which divert funds from other sectors like healthcare and education.
In 2022, the government chose the latter, freezing retail fuel prices despite global crude prices exceeding $100 per barrel. The decision cost the exchequer an estimated ₹1.5 trillion ($18 billion) in foregone revenue, according to The Economic Times. The fiscal strain forced the government to make deep cuts to social sector budgets, including a 10% reduction in funding for the National Health Mission (NHM), which supports rural healthcare. The NHM’s budget has remained stagnant at around ₹37,000 crore ($4.4 billion) since 2020, despite inflation and population growth.
The government’s flagship Ayushman Bharat scheme, launched in 2018 to provide health insurance to 500 million low-income Indians, has also been hamstrung by funding shortfalls. A 2023 audit by the Comptroller and Auditor General of India (CAG) found that only 12% of the scheme’s allocated funds were utilized in some states due to bureaucratic delays and low reimbursement rates, which deter private hospitals from participating. The scheme’s coverage is also patchy: a 2023 report by OxFam India found that 40% of eligible beneficiaries were unaware of the scheme’s existence, and many who were aware struggled to access care due to a lack of empanelled hospitals in their area.
—
Evidence and Source Trail
The financial strain on India’s public hospitals is well-documented. The National Health Systems Resource Centre (NHSRC) report, based on data from 736 district hospitals across 36 states and union territories, paints a grim picture. In addition to the lack of diagnostic equipment and staff shortages, the report found that 30% of district hospitals do not have a functioning blood bank, and 25% lack a 24-hour emergency department. The report attributed these deficiencies to “chronic underfunding and poor governance,” noting that state governments often fail to release funds on time, leading to delays in procurement and maintenance.
The oil market’s role in this crisis is equally clear. India’s fuel subsidy bill has ballooned in recent years, driven by global price volatility and the government’s reluctance to pass costs on to consumers. The Petroleum Planning and Analysis Cell (PPAC) data shows that the subsidy bill surged from ₹1.1 trillion ($13.2 billion) in 2021-22 to ₹2.2 trillion ($26.5 billion) in 2022-23. The spike forced the government to cut planned allocations for the Ayushman Bharat scheme by 15%, as reported by The Hindu in March 2023. The scheme’s budget for 2023-24 was slashed from ₹7,200 crore ($865 million) to ₹6,100 crore ($733 million), despite the government’s promise to expand coverage to all Indians by 2025.
On the private equity front, the numbers tell a story of rapid growth. Venture Intelligence data shows that private equity investments in Indian healthcare surged from $1.2 billion in 2020 to $4.5 billion in 2023. The deals span hospitals, diagnostics, and pharmaceuticals, with a particular focus on high-margin specialties. KKR’s potential $1 billion stake in Medicover’s Indian arm would be the largest healthcare deal in India’s history, surpassing its 2021 acquisition of Max Healthcare for $600 million.
However, the benefits of this investment boom are uneven. The Public Health Foundation of India (PHFI) study, which analyzed pricing data from 100 public and private hospitals across 10 states, found that private hospitals charge significantly more for the same procedures. For example, a cesarean section costs an average of ₹50,000 ($600) in a private hospital, compared to ₹10,000 ($120) in a public hospital. The study also found that private hospitals often overprescribe tests and procedures to maximize profits, a practice known as “supplier-induced demand.”
The government’s claims about increased healthcare spending are also disputed. In a 2023 press conference, Health Minister Mansukh Mandaviya argued that India’s healthcare budget had increased by 73% since 2014, citing nominal figures without adjusting for inflation or population growth. However, a 2023 report by OxFam India found that healthcare spending as a percentage of GDP had actually declined from 1.35% in 2017-18 to 1.28% in 2022-23. The report also noted that out-of-pocket healthcare expenses had risen by 15% over the same period, pushing an additional 50 million Indians into poverty annually.
—
Background and Context
India’s healthcare system has long been a tale of two sectors. The public system, built on the principles of equity and accessibility, was established after independence to provide free or low-cost care to all citizens. However, it has been plagued by underfunding, bureaucratic inefficiency, and corruption. The private sector, which emerged in the 1980s and expanded rapidly after economic liberalization in the 1990s, has filled the gap left by the public system, offering higher-quality care to those who can afford it.
The government’s Ayushman Bharat scheme, launched in 2018, was meant to bridge this gap by providing health insurance to 500 million low-income Indians. The scheme, which covers hospitalization costs up to ₹500,000 ($6,000) per family per year, is the world’s largest government-funded health insurance program. However, it has been hamstrung by low reimbursement rates, which deter private hospitals from participating, and chronic underfunding. A 2023 audit by the Comptroller and Auditor General of India (CAG) found that only 12% of the scheme’s allocated funds were utilized in some states due to bureaucratic delays and a lack of empanelled hospitals.
The oil market’s impact on healthcare is a more recent phenomenon. India’s fuel subsidy program, introduced in the 1970s to shield consumers from price shocks, has become a fiscal albatross. The government’s decision to freeze retail fuel prices during the 2022 oil crisis—despite global crude prices exceeding $100 per barrel—cost the exchequer an estimated ₹1.5 trillion ($18 billion) in foregone revenue, according to The Economic Times. The fiscal strain forced the government to make tough choices, including a 10% cut to the National Health Mission (NHM) budget, which funds rural healthcare.
The NHM’s budget has remained stagnant at around ₹37,000 crore ($4.4 billion) since 2020, despite inflation and population growth. The program, which supports over 200,000 health workers and 25,000 health facilities across India, has struggled to maintain services in the face of rising costs. In 2023, the government slashed funding for the Janani Suraksha Yojana (JSY), a scheme that provides cash incentives to pregnant women for institutional deliveries, by 20%. The cut has led to a decline in institutional deliveries in several states, increasing the risk of maternal and infant mortality.
The private sector’s growth has been fueled by a combination of factors, including rising middle-class demand, a severe shortage of public healthcare infrastructure, and favorable government policies. In 2020, the government relaxed foreign direct investment (FDI) norms for the healthcare sector, allowing 100% FDI in hospitals and diagnostic centers. The move has attracted a wave of foreign investors, including private equity firms like KKR, Blackstone, and Carlyle.
However, the private sector’s expansion has not been without controversy. Critics argue that private hospitals often prioritize profits over patients, leading to overcharging, unnecessary procedures, and poor quality of care. A 2022 investigation by The Wire found that several private hospitals in Delhi were charging patients for procedures that were not performed, or for drugs and consumables that were not used. The investigation also found that private hospitals often refuse to treat poor patients, even if they are covered under the Ayushman Bharat scheme, due to low reimbursement rates.
—
Competing Claims and Uncertainty
The government has pushed
Corrections
If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.
Story synopsis gathered from: multiple sources — source.
